Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy Model-Reference-Cited by-同舟云学术

Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy Model

Published:2021-02-24 Issue:5 Volume:89 Page:952-966
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Annals of Neurology

Author:

Litvinchuk Alexandra¹^ORCID,Huynh Tien‐Phat V.¹²^ORCID,Shi Yang¹^ORCID,Jackson Rosemary J.³^ORCID,Finn Mary B.¹,Manis Melissa¹,Francis Caroline M.¹,Tran Ainsley C.¹,Sullivan Patrick M.⁴^ORCID,Ulrich Jason D.¹^ORCID,Hyman Bradley T.³^ORCID,Cole Tracy⁵,Holtzman David M.¹^ORCID

Affiliation:

1. Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center Washington University School of Medicine St. Louis MO

2. Medical Scientist Training Program (MSTP) Washington University School of Medicine St. Louis MO

3. Department of Neurology, Harvard Medical School, MassGeneral Institute for Neurodegenerative Disease Massachusetts General Hospital Charlestown MA

4. Department of Medicine, Duke University Medical Center, Durham Veterans Health Administration Medical Center's Geriatric Research Education and Clinical Center Durham NC

5. Ionis Pharmaceuticals, Inc. Carlsbad CA

Funder

JPB Foundation

National Institutes of Health

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.26043

Reference61 articles.

1. Neuropathological Alterations in Alzheimer Disease